These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 19829042)
1. Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant! Fazlioglu A; Tandogdu Z; Kurtulus FO; Parlakkilic O; Cek M Urol Int; 2009; 83(3):362-3. PubMed ID: 19829042 [TBL] [Abstract][Full Text] [Related]
2. [Bladder necrosis after an immediate post-operative mitomycin C instillation]. Branchereau J; Luyckx F; Hitier M; Karam G; Bouchot O; Rigaud J Prog Urol; 2011 Feb; 21(2):151-3. PubMed ID: 21296285 [TBL] [Abstract][Full Text] [Related]
3. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection. Shapiro O; Jones K; Wang C; Landas S; Haas GP Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694 [TBL] [Abstract][Full Text] [Related]
4. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C. Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311 [TBL] [Abstract][Full Text] [Related]
5. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? Oddens JR; van der Meijden AP; Sylvester R Eur Urol; 2004 Sep; 46(3):336-8. PubMed ID: 15306104 [TBL] [Abstract][Full Text] [Related]
6. Intravesical mitomycin C for superficial transitional cell carcinoma. Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493 [TBL] [Abstract][Full Text] [Related]
7. Incrusted cystitis after intravesical mitomycin C treatment. Llopis M; Moreno J; Botella R; Algado M Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases. Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290 [TBL] [Abstract][Full Text] [Related]
9. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer. Mostafid AH; Rajkumar RG; Stewart AB; Singh R BJU Int; 2006 Mar; 97(3):509-12. PubMed ID: 16469017 [TBL] [Abstract][Full Text] [Related]
10. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C. Okumura A; Oishi N; Kaji K; Imamura T; Fuse H J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691 [TBL] [Abstract][Full Text] [Related]
11. Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation. Aagaard MF; Mogensen K; Hermann GG Scand J Urol; 2014 Apr; 48(2):222-4. PubMed ID: 23870006 [TBL] [Abstract][Full Text] [Related]
12. [Severe cystitis and perivesical collection posterior to Mitomycin C immediate instillation in a patient with inadverted bladder perforation]. Dini Di Stefano D; Urdaneta Pignalosa G; Rodríguez Faba O; Huguet Pérez J; Palou Redorta J; Villavicencio Mavrich H Actas Urol Esp; 2008; 32(7):759-62. PubMed ID: 18788496 [TBL] [Abstract][Full Text] [Related]
13. Increasing medical staff safety by using a closed system for intravesical instillation of mitomycin C. Haifler M; Lang E; Sabler I; Gutman Y; Lindner A; Zisman A Urology; 2010 Sep; 76(3):649-51. PubMed ID: 20493518 [TBL] [Abstract][Full Text] [Related]
14. Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C. Caso J; Qin D; Sexton WJ Can J Urol; 2010 Jun; 17(3):5223-5. PubMed ID: 20566021 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640 [TBL] [Abstract][Full Text] [Related]
16. [Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature]. Punga-Maole ML; Hubert J; Mangin P Prog Urol; 1995 Sep; 5(4):580-5. PubMed ID: 7581512 [TBL] [Abstract][Full Text] [Related]
17. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder]. Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501 [TBL] [Abstract][Full Text] [Related]
18. Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system. Feifer A; Xie X; Brophy JM; Segal R; Kassouf W Urology; 2010 Sep; 76(3):652-6. PubMed ID: 20394970 [TBL] [Abstract][Full Text] [Related]
19. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer. Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407 [TBL] [Abstract][Full Text] [Related]
20. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C. Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]